PW Medtech Group (FRA:PWE) 3-Year EBITDA Growth Rate : -23.00% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group 3-Year EBITDA Growth Rate?

PW Medtech Group's EBITDA per Share for the six months ended in Dec. 2023 was €0.01.

During the past 12 months, PW Medtech Group's average EBITDA Per Share Growth Rate was 36.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -23.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of PW Medtech Group was 94.80% per year. The lowest was -29.60% per year. And the median was -4.00% per year.

Competitive Comparison of PW Medtech Group's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, PW Medtech Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PW Medtech Group's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's 3-Year EBITDA Growth Rate falls into.

PW Medtech Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PW Medtech Group (FRA:PWE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PW Medtech Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (FRA:PWE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (FRA:PWE) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

01358:Hong Kong

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

PW Medtech Group (FRA:PWE) Headlines

No Headlines